Study Details

General Information

Otsuka Schizophrenia 248

“A 52 Week, Multicenter, Open-Label to Evaluate the Effectiveness of (study drug) Intramuscular Depot as Maintenance Treatment in Patients with Schizophrenia “(study drug) Open-Label”

Protocol31-08-248
Identifier31-08-248
UID221adda2-93e8-4c50-9ce0-b9f26bab1503
StatusDone - Archived
Phase3
CategorySchizophrenia / Adult
Launch Year2010
NCT Number-
Created2010-05-21 16:00
Last Updated2010-05-21 16:00

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2013-09-05No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMohaupt, StephenSMohauptNo
Recruiter-No
Coordinator-No
RegulatoryAguirre, SandraSAguirreNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorOtsuka Pharmaceuticals
DivisionOtsuka Pharmaceuticals
TeamOtsuka Pharmaceuticals
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref31-08-248
CROCovance -LabCorp Drug Development
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?